GemVax's Novel Peptide For Alzheimer’s Set To Advance After Positive Phase II

 
• By Jung Won Shin
  
Alzheimers_677117191_Atthapon-Raksthaput_1200.jpg
GemVax Has Advantage Not Having To Compete With Early Stage AD Drugs

More from R&D

More from Scrip